Halozyme Therapeutics (HALO) is down more than -14% after Bloomberg News reported the company submitted a $2.1 billion bid to acquire Evotec SE ... Haynes International Inc (HAYN), Inhibrx Biosciences ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈